MENINGIOMA
Clinical trials for MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMA trials appear
Sign up with your email to follow new studies for MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New platform trial takes on NF2 tumors with multiple drug strategies
Disease control Not yet recruitingThis trial tests several drugs in people with NF2-related schwannomatosis, a condition that causes tumors on nerves and in the brain. The study uses a flexible 'platform' design to evaluate treatments for four tumor types: vestibular schwannomas, non-vestibular schwannomas, menin…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
Disease control Not yet recruitingThis trial tests the drug selumetinib in people with NF2-related schwannomatosis, a genetic condition that causes non-cancerous tumors on nerves, often leading to hearing loss. The study includes both adults and children whose tumors cannot be surgically removed or are growing. R…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Drug combo aims to shrink NF2 tumors and save hearing
Disease control Not yet recruitingThis trial tests whether combining two drugs—luvometinib (a targeted therapy) and serplulimab (an immunotherapy)—can shrink tumors and improve hearing in people with NF2-related schwannomatosis. Participants have progressive vestibular schwannomas or meningiomas that are not suit…
Matched conditions: MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Which scan is better for spotting brain tumors? tiny study aims to find out
Diagnosis Not yet recruitingThis study will compare two types of PET scans (using different radioactive tracers) in 6 adults with suspected meningioma who are scheduled for surgery. Each person will get both scans at least 24 hours apart. The goal is to see which tracer gives clearer images of the tumor, wh…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Could a simple drug stop confusion after brain surgery?
Symptom relief Not yet recruitingThis study tests whether a medicine called dexmedetomidine can reduce pain and prevent confusion (delirium) in adults after brain surgery. Sixty people having planned brain tumor removal will receive either the drug or a placebo during surgery. The goal is to see if it lowers pai…
Matched conditions: MENINGIOMA
Phase: NA • Sponsor: University of Malaya • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Personalized drug test aims to outsmart refractory brain tumors
Knowledge-focused Not yet recruitingThis study tests a lab technique called pharmacoscopy that analyzes a patient's tumor tissue to find which drugs might work best for them. It includes 40 adults with various aggressive or rare brain tumors that have not responded to standard treatments. The main goal is to see if…
Matched conditions: MENINGIOMA
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could a prostate cancer imaging tool help fight brain tumors?
Knowledge-focused Not yet recruitingThis study tests whether a special PET scan (PSMA PET) can detect a protein on recurrent meningiomas, a common brain tumor. If the protein is present, it might allow a new type of targeted radiation therapy. The study involves 40 adults whose meningioma has come back after standa…
Matched conditions: MENINGIOMA
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New study aims to better understand meningioma Patients' quality of life
Knowledge-focused Not yet recruitingThis study tests a French questionnaire designed to measure quality of life in adults with meningioma, a type of brain tumor. About 238 participants will fill out online surveys about their well-being. No treatment or extra visits are involved—just questionnaires. The goal is to …
Matched conditions: MENINGIOMA
Sponsor: Centre Hospitalier St Anne • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC